Date: March 12, 2026
This report provides a comprehensive analysis of the Quality Measurement Methodology for the Accountable Care Organization Realizing Equity, Access, and Community Health (ACO REACH) Model for Performance Year (PY) 2025. The ACO REACH Model, administered by the Centers for Medicare & Medicaid Services (CMS) and implemented by RTI International, represents a significant redesign of value-based care delivery, running from January 1, 2023, through December 31, 2026 8|PDF. The PY 2025 methodology, detailed in the "May 2025 ACO REACH Model PY 2025 Quality Measurement Methodology Report," establishes the framework for assessing the performance of Accountable Care Organizations (ACOs) across three distinct cohorts: Standard, New Entrant, and High Needs Population 8|PDF.
This research addresses a critical distinction in nomenclature: the "ACO REACH Model" refers to a healthcare delivery and payment model, not an "Ant Colony Optimization" algorithm. While search results for the latter exist in computational contexts 2|PDFthey are distinct from the healthcare policy framework discussed herein. The PY 2025 methodology integrates complex statistical models for risk adjustment, benchmarking, and performance scoring. Key components include the calculation of risk-standardized quality measures—specifically the All-Cause Readmission (ACR) rate and the Unplanned Acute Medical Care for Chronically Ill (UAMCC) rate—alongside patient experience surveys (CAHPS) and health equity adjustments 8|PDF8|PDF.
The methodology for PY 2025 introduces refined risk adjustment blending, utilizing 33% of the 2020 (V24) model and 67% of the 2024 (V28) model for financial benchmarks, alongside a Coding Intensity Factor (CIF) capped at 1% 14|PDF14|PDF. Furthermore, the scoring architecture incorporates a Continuous Improvement/Sustained Exceptional Performance (CI/SEP) multiplier, which acts as a critical financial lever, applying a 0.5 penalty multiplier to ACOs failing to meet specific improvement or high-performance thresholds 8|PDF. The integration of Social Determinants of Health (SDOH) data via the Health Equity Data Reporting (HEDR) adjustment further evolves the model, offering a potential 5% bonus to quality scores for comprehensive data reporting 8|PDF13|PDF. This report details the statistical underpinnings, data requirements, and operational mechanics of these components.
It is imperative to establish the correct context for the "ACO REACH Model." Search queries often conflate the acronym "ACO" with "Ant Colony Optimization," a swarm intelligence algorithm used in computational mathematics for solving optimization problems like the Traveling Salesman Problem 2|PDF. However, within the scope of the "ACO REACH Model PY 2025 Quality Measurement Methodology Report," the term exclusively refers to the Accountable Care Organization Realizing Equity, Access, and Community Health Model 19|PDF20|PDF.
This model is a healthcare initiative designed by CMS to test interventions for improving quality and reducing costs for Medicare Fee-For-Service (FFS) beneficiaries 8|PDF. There is no evidence in the supplied literature of a Python-based algorithmic implementation of a "REACH Model" within the computational sense; rather, the "model" is a policy and financial framework analyzed using statistical software 3|PDF. The "PY" in the research topic stands for "Performance Year," specifically 2025, rather than an abbreviation for the Python programming language.
The ACO REACH Model was designed as a redesign of the Global and Professional Direct Contracting (GPDC) Model options 8|PDF13|PDF. The model's timeline is structured as follows:
The primary objective of the model is to realize the goals of value-based care: reducing expenditures while preserving or enhancing the quality of care 8|PDF. The methodology report serves as the technical manual for how "quality" is defined, measured, and translated into financial settlements.
The PY 2025 quality measurement framework is built upon five primary quality measures, applied differentially based on the ACO type (Standard, New Entrant, or High Needs Population). These measures are categorized into claims-based metrics and survey-based metrics 8|PDF.
The ACR measure is a fundamental indicator of care coordination and post-discharge management. It is defined as the percentage of hospital admissions for REACH ACO-aligned beneficiaries that result in an unplanned readmission within 30 days of discharge 10|PDF40|PDF. Lower values indicate superior performance 10|PDF.
The UAMCC measure focuses on a high-cost, high-need segment of the Medicare population: beneficiaries with multiple chronic conditions. It measures the rate of acute, unplanned hospital admissions 8|PDF8|PDF.
The DAH measure is a patient-centric metric specifically designed for the High Needs Population cohort. It quantifies the number of days patients with complex chronic diseases spend at home or in the community, as opposed to acute care or post-acute care settings 8|PDF13|PDF.
TFU measures the effectiveness of care transitions. It tracks the percentage of acute events (such as emergency room visits or hospitalizations) where the patient receives follow-up care within recommended timeframes in non-emergency settings 8|PDF13|PDF.
The CAHPS survey provides the patient's perspective on care quality. It assesses patient satisfaction and experience with the ACO's providers and services 8|PDF13|PDF.
The integrity of the ACO REACH Model relies on sophisticated statistical methods to ensure that quality scores reflect performance rather than differences in patient risk profiles. The methodology bifurcates risk adjustment into two primary domains: Quality Risk Standardization (used for ACR and UAMCC measures) and Payment Risk Adjustment (used for benchmarking and financial settlements).
For the ACR and UAMCC measures, the model employs risk-standardized indicators to account for underlying differences in patient health status 8|PDF. The core methodology involves hierarchical modeling.
For financial benchmarking and calculating expenditure targets, the model utilizes prospective and concurrent risk adjustment models based on Hierarchical Condition Categories (HCC) 14|PDF19|PDF.
Quality Performance Benchmarks (QPBs) are the reference points against which ACO performance is measured. The methodology for deriving these benchmarks is pivotal to the scoring process.
QPBs are developed for each Pay-for-Performance (P4P) quality measure 8|PDF8|PDF. The statistical derivation relies on the distribution of performance data across the REACH ACO cohort.
The model recognizes the heterogeneity among ACO types. Separate QPBs are established for:
This segmentation prevents unfair comparisons between ACOs managing general populations and those managing complex, high-needs patients, whose outcome metrics (like DAH) and risk profiles differ substantially.
The Total Quality Score is the composite metric that directly influences financial settlements. Its calculation is a multi-step process involving initial scoring, adjustments, and multipliers.
The IQS is derived by comparing the ACO's performance rates on each quality measure against the established QPBs 8|PDF8|PDF. Points are awarded based on the decile or percentile of performance.
The Continuous Improvement/Sustained Exceptional Performance (CI/SEP) criteria represent a unique feature of the ACO REACH Model, designed to reward consistent high performance or demonstrable improvement. This framework acts as a multiplier to the Initial Quality Score.
The Multiplier Logic:
CI/SEP Criteria Thresholds:
To achieve a multiplier of 1.0, an ACO must satisfy both of the following conditions 8|PDF35|PDF:
PY 2025 sees the full implementation of the HEDR adjustment, integrating Social Determinants of Health (SDOH) into the quality architecture.
A Data Reporting Adjustment is also part of the Total Quality Score calculation, ensuring ACOs meet basic administrative data submission requirements. While less emphasized than CI/SEP or HEDR in the provided snippets, it is a component of the final score derivation 8|PDF8|PDF.
The theoretical flow of the calculation for the Total Quality Score in PY 2025 is:
The robustness of the methodology depends on the underlying data infrastructure.
The primary data source for claims-based measures (ACR, UAMCC, TFU, DAH) is the Medicare FFS claims database.
Patient experience data is collected via the CAHPS survey, administered by approved vendors 8|PDF13|PDF. This data is distinct from administrative claims and is merged with the quality dataset to form the complete performance profile.
For the HEDR adjustment, ACOs must submit structured SDOH data. This represents a shift toward incorporating non-clinical data into value-based care models 8|PDF.
The methodology explicitly addresses statistical uncertainty.
The inclusion of the HEDR adjustment in PY 2025 marks a significant evolution in CMS strategy. By tying up to 5% of the quality score directly to the collection of SDOH data, the model mandates that ACOs develop infrastructure to identify and address social needs 8|PDF. This moves beyond mere clinical accountability to holistic population health management. The requirement to use validated assessment tools ensures data standardization, potentially enabling future risk adjustment for social factors 8|PDF.
The CI/SEP multiplier mechanism is a powerful behavioral lever. The stark difference between a 1.0 and 0.5 multiplier creates a "cliff" that disproportionately penalizes ACOs near the threshold 8|PDF. This design prioritizes:
The blending of V24 and V28 HCC models (33%/67%) demonstrates CMS's approach to managing model transitions 14|PDF. By phasing in the V28 model— which generally reduces the number of HCC categories and revises coding mappings—CMS allows ACOs to adapt their documentation and coding practices. The 1% Coding Intensity Factor cap 14|PDF further reflects a conservative approach to financial integrity, preventing expenditure growth driven purely by coding proliferation rather than true risk increases.
The ACO REACH Model PY 2025 Quality Measurement Methodology represents a mature and complex framework for value-based accountability. It balances the need for rigorous, risk-standardized clinical metrics (ACR, UAMCC) with patient-reported outcomes (CAHPS) and emerging priorities in health equity (HEDR).
The statistical architecture, relying on hierarchical modeling for quality measures and HCC models for financial risk, ensures that comparisons are fair and robust to random variation. The innovative CI/SEP scoring mechanism introduces a high-stakes incentive for sustained excellence or improvement, while the integration of SDOH data signals the future direction of Medicare alternative payment models.
As the model progresses toward its conclusion in 2026, the data generated from PY 2025—under these specific methodological constraints—will be critical for evaluating whether the ACO REACH Model has successfully realized its mandate of improving equity, access, and community health while controlling costs. The final Quality Performance Benchmarks, to be released in June 2026, will provide the definitive scale against which the success of participating ACOs is measured.